Royal Bank Of Canada Immunic, Inc. Transaction History
Royal Bank Of Canada
- $458 Billion
- Q1 2025
A detailed history of Royal Bank Of Canada transactions in Immunic, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 45 shares of IMUX stock, worth $39. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 45
-0.0%
Holding current value
$39
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IMUX
# of Institutions
71Shares Held
47.2MCall Options Held
1.14MPut Options Held
130K-
Bvf Inc San Francisco, CA8.9MShares$7.75 Million0.43% of portfolio
-
Abrdn PLC8.24MShares$7.17 Million0.01% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$6.34 Million0.66% of portfolio
-
Avidity Partners Management LP Dallas, TX4.45MShares$3.88 Million1.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.13MShares$3.59 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $26.6M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...